BioCentury

8:00 AM GMT, Feb 21, 2011
This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.
Clinical Status

LY2127399: Phase III started

Eli Lilly disclosed in its 4Q10 earnings that it began a double-blind, placebo-controlled, U.S. Phase III trial

Read the full 175 word article

This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.